Wetherby Asset Management Inc. decreased its position in Danaher Corporation (NYSE:DHR) by 1.2% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 15,347 shares of the conglomerate’s stock after selling 189 shares during the quarter. Wetherby Asset Management Inc.’s holdings in Danaher Corporation were worth $1,295,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors have also recently made changes to their positions in DHR. BlackRock Inc. grew its stake in shares of Danaher Corporation by 2,530.9% in the 1st quarter. BlackRock Inc. now owns 37,967,922 shares of the conglomerate’s stock valued at $3,247,398,000 after buying an additional 36,524,795 shares in the last quarter. Flossbach Von Storch AG grew its stake in shares of Danaher Corporation by 44.7% in the 2nd quarter. Flossbach Von Storch AG now owns 5,782,019 shares of the conglomerate’s stock valued at $487,945,000 after buying an additional 1,785,810 shares in the last quarter. Vanguard Group Inc. grew its stake in shares of Danaher Corporation by 3.9% in the 1st quarter. Vanguard Group Inc. now owns 40,967,631 shares of the conglomerate’s stock valued at $3,503,962,000 after buying an additional 1,530,015 shares in the last quarter. MARSHALL WACE ASIA Ltd bought a new stake in shares of Danaher Corporation in the 1st quarter valued at approximately $116,462,000. Finally, Marshall Wace North America L.P. bought a new stake in shares of Danaher Corporation in the 1st quarter valued at approximately $116,462,000. 75.75% of the stock is owned by institutional investors and hedge funds.
In other news, insider Thomas Patrick Joyce, Jr. sold 9,772 shares of Danaher Corporation stock in a transaction that occurred on Monday, July 31st. The stock was sold at an average price of $81.78, for a total transaction of $799,154.16. Following the completion of the transaction, the insider now directly owns 155,520 shares in the company, valued at approximately $12,718,425.60. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider William King sold 7,458 shares of Danaher Corporation stock in a transaction that occurred on Friday, July 21st. The stock was sold at an average price of $82.97, for a total value of $618,790.26. Following the transaction, the insider now owns 18,245 shares of the company’s stock, valued at $1,513,787.65. The disclosure for this sale can be found here. Insiders have sold a total of 71,496 shares of company stock valued at $5,916,223 over the last quarter. 12.20% of the stock is currently owned by corporate insiders.
Several brokerages recently commented on DHR. J P Morgan Chase & Co reissued an “overweight” rating and issued a $95.00 price target on shares of Danaher Corporation in a research note on Friday, September 8th. Janney Montgomery Scott cut Danaher Corporation from a “buy” rating to a “neutral” rating in a research note on Wednesday, June 7th. BidaskClub raised Danaher Corporation from a “sell” rating to a “hold” rating in a research note on Wednesday, June 21st. Deutsche Bank AG reissued a “buy” rating and issued a $97.00 price target on shares of Danaher Corporation in a research note on Wednesday, June 21st. Finally, Zacks Investment Research cut Danaher Corporation from a “hold” rating to a “sell” rating in a research note on Monday, June 19th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, twelve have assigned a buy rating and one has given a strong buy rating to the company’s stock. The stock has an average rating of “Buy” and an average target price of $92.72.
Danaher Corporation (DHR) opened at 88.21 on Friday. The stock’s 50 day moving average price is $82.64 and its 200-day moving average price is $84.22. Danaher Corporation has a one year low of $75.71 and a one year high of $88.48. The firm has a market capitalization of $61.28 billion, a price-to-earnings ratio of 28.16 and a beta of 1.03.
Danaher Corporation (NYSE:DHR) last issued its earnings results on Thursday, July 20th. The conglomerate reported $0.99 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.97 by $0.02. Danaher Corporation had a return on equity of 11.15% and a net margin of 12.63%. The company had revenue of $4.51 billion during the quarter, compared to the consensus estimate of $4.50 billion. During the same period in the previous year, the company posted $0.90 EPS. The firm’s revenue for the quarter was up 6.3% compared to the same quarter last year. On average, equities research analysts expect that Danaher Corporation will post $3.95 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Friday, September 29th will be paid a dividend of $0.14 per share. The ex-dividend date is Thursday, September 28th. This represents a $0.56 annualized dividend and a dividend yield of 0.63%. Danaher Corporation’s dividend payout ratio is currently 17.83%.
WARNING: “Wetherby Asset Management Inc. Sells 189 Shares of Danaher Corporation (DHR)” was originally reported by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are reading this article on another website, it was illegally stolen and reposted in violation of United States & international copyright & trademark law. The correct version of this article can be read at https://www.chaffeybreeze.com/2017/09/17/wetherby-asset-management-inc-sells-189-shares-of-danaher-corporation-dhr.html.
Danaher Corporation Company Profile
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).
Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.